The glycocalyx regulates the uptake of nanoparticles by human endothelial cells in vitro.

AIM To assess the role of the endothelial glycocalyx (eGCX) for the uptake of nanoparticles by endothelial cells. METHODS The expression of the eGCX on cultured human umbilical vein endothelial cells was determined by immunostaining of heparan sulfate. Enzymatic degradation of the eGCX was achieved by incubating the cells with eGCX-shedding enzymes. The uptake of 50-nm polystyrene nanospheres was quantified by confocal microscopy. RESULTS Human umbilical vein endothelial cells expressed a robust eGCX when cultured for 10 days. The uptake of both carboxylated and aminated polystyrene nanospheres was significantly increased in cells in which the glycocalyx was enzymatically degraded, while it remained at a low level in cells with an intact glycocalyx. CONCLUSION The eGCX constitutes a barrier against the internalization of blood-borne nanoparticles by endothelial cells.

[1]  L. Kubala,et al.  Modulation of Endothelial Glycocalyx Structure under Inflammatory Conditions , 2014, Mediators of inflammation.

[2]  John M Tarbell,et al.  Mechano‐sensing and transduction by endothelial surface glycocalyx: composition, structure, and function , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[3]  Bengt Fadeel,et al.  Safety assessment of nanomaterials: implications for nanomedicine. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  V. Nurcombe,et al.  Isolation of a native osteoblast matrix with a specific affinity for BMP2 , 2007, Journal of Molecular Histology.

[5]  Dick W. Slaaf,et al.  The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.

[6]  Francesco Stellacci,et al.  Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes. , 2015, Nanoscale.

[7]  Wolfgang J. Parak,et al.  Protein corona formation around nanoparticles – from the past to the future , 2014 .

[8]  D. Chappell,et al.  Serum heparan sulfate levels are elevated in endotoxemia , 2009, European Journal of Medical Research.

[9]  A. Mulivor,et al.  Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.

[10]  H. Lipowsky.  The Endothelial Glycocalyx as a Barrier to Leukocyte Adhesion and Its Mediation by Extracellular Proteases , 2011, Annals of Biomedical Engineering.

[11]  J. Powell,et al.  Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers , 2015, Particle and Fibre Toxicology.

[12]  J. Tarbell,et al.  The Structural Stability of the Endothelial Glycocalyx after Enzymatic Removal of Glycosaminoglycans , 2012, PloS one.

[13]  U. Welsch,et al.  Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx , 2008, Biological chemistry.

[14]  B. Duling,et al.  Capillary endothelial surface layer selectively reduces plasma solute distribution volume. , 2000, American journal of physiology. Heart and circulatory physiology.

[15]  Eva Roblegg,et al.  Cytotoxicity of nanoparticles independent from oxidative stress. , 2009, The Journal of toxicological sciences.

[16]  Wolfgang G Kreyling,et al.  Nanoparticles in the lung , 2010, Nature Biotechnology.

[17]  G. Villa,et al.  Glycocalyx and sepsis-induced alterations in vascular permeability , 2015, Critical Care.

[18]  Sheldon Weinbaum,et al.  The structure and function of the endothelial glycocalyx layer. , 2007, Annual review of biomedical engineering.

[19]  B. Sharrack,et al.  Transport of Gold Nanoparticles by Vascular Endothelium from Different Human Tissues , 2016, PloS one.

[20]  M. Jacob,et al.  Endothelial glycocalyx and coronary vascular permeability: the fringe benefit , 2010, Basic Research in Cardiology.

[21]  E. Damiano,et al.  The Hydrodynamically Relevant Endothelial Cell Glycocalyx Observed In Vivo Is Absent In Vitro , 2008, Circulation research.

[22]  Sheldon Weinbaum,et al.  The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper-car" model. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  David C Spray,et al.  Imaging the Endothelial Glycocalyx In Vitro by Rapid Freezing/Freeze Substitution Transmission Electron Microscopy , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[24]  P. Lichter,et al.  Histone acetylation increases chromatin accessibility , 2005, Journal of Cell Science.

[25]  J. Spaan,et al.  Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. , 2003, American journal of physiology. Heart and circulatory physiology.

[26]  C. Ince,et al.  Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. , 2005, Journal of applied physiology.

[27]  V. Hlady,et al.  Bioengineering the Lung : Molecules , Materials , Matrix , Morphology , and Mechanics Use of reflectance interference contrast microscopy to characterize the endothelial glycocalyx stiffness , 2012 .

[28]  H. Oberleithner,et al.  Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis , 2011, Pflügers Archiv - European Journal of Physiology.

[29]  F. Krombach,et al.  Surface chemistry of quantum dots determines their behavior in postischemic tissue. , 2012, ACS nano.

[30]  Robert H. Jenkins,et al.  Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro. , 2013, The American journal of pathology.

[31]  R. Rodseth,et al.  The endothelial glycocalyx: a review of the vascular barrier , 2014, Anaesthesia.

[32]  K. Bentley.  An 11-μm-Thick Glycocalyx?: It's All in the Technique! , 2011 .

[33]  Mauro Ferrari,et al.  Nanomedicine--challenge and perspectives. , 2009, Angewandte Chemie.

[34]  J. Spaan,et al.  Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. , 2001, American journal of physiology. Heart and circulatory physiology.

[35]  U. Welsch,et al.  The Glycocalyx of the Human Umbilical Vein Endothelial Cell: An Impressive Structure Ex Vivo but Not in Culture , 2009, Circulation research.

[36]  U. Welsch,et al.  The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo. , 2010, Biomaterials.

[37]  T. Bein,et al.  Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery , 2014 .

[38]  F. Gao,et al.  The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy. , 2013, Biomaterials.

[39]  Thomas J Webster,et al.  Endothelial glycocalyx conditions influence nanoparticle uptake for passive targeting , 2016, International journal of nanomedicine.

[40]  J. Michaelis,et al.  A fast analysis method to quantify nanoparticle uptake on a single cell level. , 2013, Nanomedicine.

[41]  K. Peter,et al.  Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional Ischemia , 2007, Circulation.

[42]  Chor Yong Tay,et al.  Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.

[43]  Wen Wang,et al.  Spatio-temporal development of the endothelial glycocalyx layer and its mechanical property in vitro , 2012, Journal of The Royal Society Interface.

[44]  M. Jacob,et al.  Protection of glycocalyx decreases platelet adhesion after ischaemia/reperfusion: An animal study , 2014, European journal of anaesthesiology.

[45]  J. Tarbell,et al.  Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model. , 2016, Atherosclerosis.

[46]  Matthias Wacker,et al.  Nanocarriers for intravenous injection--the long hard road to the market. , 2013, International journal of pharmaceutics.